ACADIA Pharmaceuticals Inc. Stock Analysis
Technical stock analysis for 22 January 2019
ACADIA Pharmaceuticals Inc. fell by -3.56% in the last day from $21.07 to $20.32 and has now fallen 4 days in a row. The price has risen in 6 of the last 10 days and is up by 11.46% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -1.14 million shares and in total 1.47 million shares bought and sold for approximately $29.90 million.
Close price at the end of the last trading day (Tuesday, 22nd Jan 2019) of the ACAD stock was $20.32. This is 3.56% less than the trading day before Friday, 18th Jan 2019.
During day the stock fluctuated 3.44% from a day low at $20.18 to a day high of $20.87.
30 day high of the ACAD stock price was $22.12 and low was $14.01.
90 day high was $23.55 and low was $14.01.
52 week high for the ACADIA Pharmaceuticals Inc. - $32.99 and low - $12.77.
ACADIA Pharmaceuticals Inc. lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $21.66 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -9.01% during the next 3 months and, with 90% probability hold a price between $12.44 and $19.71 at the end of this period.
ACADIA Pharmaceuticals Inc. holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $21.12. On a fall, the stock will find some support from the long-term average at approximately $18.28. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday January 16, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
The stock holds a RSI14 at 73 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
Support & Resistance
ACADIA Pharmaceuticals Inc. finds support from accumulated volume at $20.00.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.70 between high and low, or 3.44%. For the last week, the stock has had a daily average volatility of 3.67%.
The stock is overbought on RSI14 and the RSI has been falling for the last couple of days. This together with the fact that the stock is in the upper part of the trend poses a possible good selling opportunity for the short-term trader. However, one should note that some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stoploss: $18.85 (-7.25%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 73 and this increases the risk substantially. There is a sell signal from pivot top found 3 days ago.)
Very Low Low Medium High Very High
ACADIA Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development.
|ACAD $20.32 $-0.75(-3.56%)|
ACAD is down $0.75 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACAD based on the 1-3 month system that more than doubles the S&P 500.
Click here – the ACAD analysis is free »